We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA, BIO and Nevada Agree to End Price Transparency Litigation
PhRMA, BIO and Nevada Agree to End Price Transparency Litigation
PhRMA, the Biotechnology Innovation Organization (BIO) and the State of Nevada agreed to dismiss a case regarding the constitutionality of a Nevada drug pricing law that required companies to disclose confidential business information.